PET/CT of esophageal cancer: its role in clinical management.
about
Conventional radiological strategy of common gastrointestinal neoplasms18F-deoxyglucose positron emission tomography/computed tomography to predict local failure in esophageal squamous cell carcinoma.Impact of Endoscopic Ultrasonography on 18F-FDG-PET/CT Upfront Towards Patient Specific Esophageal Cancer Treatment.The role of FDG-PET and staging laparoscopy in the management of patients with cancer of the esophagus or gastroesophageal junction.Proposed follow up programme after curative resection for lower third oesophageal cancer.Radiation-induced liver disease as a mimic of liver metastases at serial PET/CT during neoadjuvant chemoradiation of distal esophageal cancer.Relationship between the Temporal Changes in Positron-Emission-Tomography-Imaging-Based Textural Features and Pathologic Response and Survival in Esophageal Cancer Patients.A study about different findings of PET-CT between neoadjuvant and non-neoadjuvant therapy: SUVmax is not a reliable predictor of lymphatic involvement after neoadjuvant therapy for esophageal cancer.Role of Pre-therapeutic (18)F-FDG PET/CT in Guiding the Treatment Strategy and Predicting Prognosis in Patients with Esophageal Carcinoma.Detection of lymph node metastases with ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging in oesophageal cancer: a feasibility studyClinical impact of FDG PET-CT on management decisions for patients with primary biliary tumours.Modern management of rare brain metastases in adults.Patterns of lymphatic drainage and lymph node involvement in esophageal cancer.Multimodality imaging evaluation of esophageal cancer: staging, therapy assessment, and complications.State-of-the-art molecular imaging in esophageal cancer management: implications for diagnosis, prognosis, and treatment.Positron emission tomography-computed tomography of esophageal adenocarcinoma with vascular invasion and tumor thrombus.Stage-directed individualized therapy in esophageal cancer.Staging Early Esophageal Cancer.Positron Emission Tomography's Utility in Esophageal Cancer ManagementPositron emission tomography's changing significance in the treatment of esophageal cancerThe Comparison of Computed Tomography Perfusion, Contrast-Enhanced Computed Tomography and Positron-Emission Tomography/Computed Tomography for the Detection of Primary Esophageal Carcinoma.Radiation-induced liver injury mimicking liver metastases on FDG-PET-CT after chemoradiotherapy for esophageal cancer : A retrospective study and literature review.Survival based radiographic-grouping for esophageal squamous cell carcinoma may impact clinical T stage.Accuracy of PET-CT in predicting survival in patients with esophageal cancer.The role of integrated F-18-FDG-PET scanning in the detection of M1 disease in oesophageal adenocarcinoma and impact on clinical management.Clinical implication of the innovations of the 8 edition of the TNM classification for esophageal and esophago-gastric cancer
P2860
Q26829763-A8BB662D-AE84-4365-A3B4-5AECF295E5D7Q33798433-5C64F727-2ED5-4D26-8F18-B26DF7C716CEQ33841583-5F67F53F-850A-4702-876F-DC9582AE37E2Q33902475-F3F8A4BF-D9CA-47E8-B3E5-5883F64B774DQ34133427-B274928C-6934-4550-B463-FE354AF5A281Q34216771-BF7DB00F-76E9-4A68-ABCA-F7696F37C6A1Q34521659-561B8CD5-8C36-4847-B22A-699AE5A0D04FQ36829696-5C12C9C9-4C38-4064-911C-ED67622A9561Q37080068-2BE31398-70F7-4949-BBFD-1D159D9F6A39Q37190023-0F68FB47-62D3-4758-876C-4AF6C8E4980AQ37192828-3F685025-EBD1-40D9-89D6-F7550C241D77Q37892462-5E194BC2-0637-4798-AE1E-C96CC8F31DE5Q38019830-74A829A1-7CB2-4EE2-98C0-764A9113975FQ38107133-23A60FC6-9DE5-433C-ADBA-FC4DA89A70DDQ38340518-57D4B6CB-B4D2-49B9-AA2B-8D7FBD259916Q38886029-F3C757F9-33D3-47B7-B3E1-2A8696AE2927Q38888100-B9A1D86B-A6CD-43CD-AA2F-8C209D9E1260Q38940521-1F77F809-3D0F-40C9-BDB9-3359213F28DDQ40341515-82ACB11C-FF47-4295-8CA8-571D20C144E5Q41135973-F705B6A0-34EC-4791-9D2D-5624F64D6118Q42756213-DA64CF70-776C-43DA-A06A-54A070AD4FCEQ47238607-D27AFA75-15B8-4F52-8261-E1AB2EE7DB6AQ51744119-C724B776-CFEA-4BA3-B5D4-DAE356596554Q53173085-9316DAAC-8A2E-4FB6-81D1-D450BF34A7E3Q53215589-9416597E-0683-4218-9511-473B9E46A0A2Q57824586-24BB1347-2B12-4EE3-BE2A-CAD301BC8B6E
P2860
PET/CT of esophageal cancer: its role in clinical management.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
PET/CT of esophageal cancer: its role in clinical management.
@ast
PET/CT of esophageal cancer: its role in clinical management.
@en
PET/CT of esophageal cancer: its role in clinical management.
@nl
type
label
PET/CT of esophageal cancer: its role in clinical management.
@ast
PET/CT of esophageal cancer: its role in clinical management.
@en
PET/CT of esophageal cancer: its role in clinical management.
@nl
prefLabel
PET/CT of esophageal cancer: its role in clinical management.
@ast
PET/CT of esophageal cancer: its role in clinical management.
@en
PET/CT of esophageal cancer: its role in clinical management.
@nl
P2093
P356
P1433
P1476
PET/CT of esophageal cancer: its role in clinical management.
@en
P2093
Bradley S Sabloff
Edith M Marom
Homer A Macapinlac
Jeremy J Erasmus
John F Bruzzi
Mylene T Truong
Revathy B Iyer
Tin-Su Pan
P304
P356
10.1148/RG.276065742
P577
2007-11-01T00:00:00Z